Literature DB >> 17909154

Serum uric acid and brain ischemia in normal elderly adults.

D J Schretlen1, A B Inscore, T D Vannorsdall, M Kraut, G D Pearlson, B Gordon, H A Jinnah.   

Abstract

BACKGROUND: Uric acid (UA) has antioxidant properties yet when elevated is associated with vascular disease and stroke. Further, even high normal UA is associated with increased risk of mild cognitive dysfunction in elderly adults.
METHOD: In this cross-sectional, observational study, we examined the relationship between serum UA and aggregate volume of white matter hyperintense (WMH) signals observed on proton density and T2-weighted brain MR images in a community sample of 177 adults ages 20 to 92. Using logistic regression, we tested whether participants with UA concentrations in the highest quartile of the sample--but still normal--would have increased WMH volumes.
RESULTS: Compared with those with low to moderate levels, participants with high normal serum UA were more likely to fall in the highest quartile of WMH volume. The odds ratios (95% CIs) of increased WMH were 2.6 (1.2 to 5.4) for total, 2.5 (1.2 to 5.1) for periventricular, and 2.8 (1.4 to 5.9) for subcortical WMH volume. After controlling for age, sex, race, education, body mass, hypertension, and diabetes, the multivariate-adjusted odds of large total and subcortical WMH volumes remained elevated. Finally, high normal UA increased the odds of having excessive ischemic burden four- to fivefold in adults ages 60 and older.
CONCLUSIONS: These findings demonstrate that mildly elevated serum uric acid is associated with increased burden of cerebral ischemic pathology, particularly in older adults. We outline the potential pathogenesis of this association. A clinical trial of antihyperuricemic medication to treat or prevent chronic brain ischemia might be warranted.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17909154     DOI: 10.1212/01.wnl.0000277468.10236.f1

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  49 in total

1.  Uric acid: a danger signal from the RNA world that may have a role in the epidemic of obesity, metabolic syndrome, and cardiorenal disease: evolutionary considerations.

Authors:  Richard J Johnson; Miguel A Lanaspa; Eric A Gaucher
Journal:  Semin Nephrol       Date:  2011-09       Impact factor: 5.299

2.  Study of epidemiological aspects of hyperuricemia in Poland.

Authors:  Katarzyna Kostka-Jeziorny; Krystyna Widecka; Andrzej Tykarski
Journal:  Cardiol J       Date:  2019-06-21       Impact factor: 2.737

3.  Role of metabolic syndrome components in human immunodeficiency virus-associated stroke.

Authors:  Beau M Ances; Archana Bhatt; Florin Vaida; Debralee Rosario; Terry Alexander; Jennifer Marquie-Beck; Ronald J Ellis; Scott Letendre; Igor Grant; J Allen McCutchan
Journal:  J Neurovirol       Date:  2009-05       Impact factor: 2.643

4.  Hyperuricemia is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes.

Authors:  A Mantovani; R Rigolon; I Pichiri; M Pernigo; C Bergamini; G Zoppini; E Bonora; G Targher
Journal:  J Endocrinol Invest       Date:  2015-07-16       Impact factor: 4.256

5.  Serum uric acid and impaired cognitive function in a cohort of healthy young elderly: data from the Brisighella Study.

Authors:  Arrigo Francesco Giuseppe Cicero; Giovambattista Desideri; Giulia Grossi; Riccardo Urso; Martina Rosticci; Sergio D'Addato; Claudio Borghi
Journal:  Intern Emerg Med       Date:  2014-07-02       Impact factor: 3.397

6.  Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk: 2021 update.

Authors:  Claudio Borghi; Justyna Domienik-Karłowicz; Andrzej Tykarski; Krystyna Widecka; Krzysztof J Filipiak; Miłosz J Jaguszewski; Krzysztof Narkiewicz; Giuseppe Mancia
Journal:  Cardiol J       Date:  2021-01-13       Impact factor: 2.737

7.  The relationship between body mass index and uric acid: a study on Japanese adult twins.

Authors:  Kentaro Tanaka; Soshiro Ogata; Haruka Tanaka; Kayoko Omura; Chika Honda; Kazuo Hayakawa
Journal:  Environ Health Prev Med       Date:  2015-06-03       Impact factor: 3.674

8.  The potential for xanthine oxidase inhibition in the prevention and treatment of cardiovascular and cerebrovascular disease.

Authors:  Peter Higgins; Jesse Dawson; Matthew Walters
Journal:  Cardiovasc Psychiatry Neurol       Date:  2009-11-04

9.  Cranial volume, mild cognitive deficits, and functional limitations associated with diabetes in a community sample.

Authors:  Andrea L Christman; Tracy D Vannorsdall; Godfrey D Pearlson; Felicia Hill-Briggs; David J Schretlen
Journal:  Arch Clin Neuropsychol       Date:  2009-11-25       Impact factor: 2.813

Review 10.  Gout. Hyperuricemia and cardiovascular disease: how strong is the evidence for a causal link?

Authors:  Angelo L Gaffo; N Lawrence Edwards; Kenneth G Saag
Journal:  Arthritis Res Ther       Date:  2009-08-19       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.